Navigation Links
Wenyong Wang Joins Science Center as Vice President, Science & Technology
Date:8/3/2017

Dr. Wenyong Wang, Ph.D., MBA has joined the University City Science Center as Vice President, Science & Technology.

Dr. Wang will oversee the Science Center’s programs for commercialization, startup investment and business incubation including QED, Phase 1 Ventures, the Digital Health Accelerator, and the Port business incubators. He will also be responsible for initiating, designing and developing new programs to further the Science Center’s mission as a nucleus for innovation, entrepreneurship and technology commercialization.

Dr. Wang was most recently Vice President, Business Development, for Adaptimmune LLC. Prior to joining Adaptimmune, Dr. Wang was Managing Director of Investment Banking at Evolution Life Science Partners.

“Wenyong’s experience in the life sciences industry and financial sectors positions him well to leverage the accomplishments of the Science & Technology team and set a vision for the future of our business incubation and technology commercialization offerings,” says Science Center President & CEO Stephen S. Tang, Ph.D., MBA.

Dr. Wang has also served as Managing Director of Burrill Securities, and has held Director and Vice President positions at investment banks, Boenning & Scattergood, Inc. and Janney Montgomery Scott. In these roles, Dr. Wang leveraged his scientific expertise and business acumen to provide guidance to pharmaceutical and biotech clients seeking to enhance their portfolios and grow their businesses.

Before joining the investment banking industry, Dr. Wang was a principal scientist in R&D with GlaxoSmithKline, conducting oncology and autoimmune research, and he oversaw two drug candidates from discovery through clinical development.

Dr. Wang holds a Ph.D. in Organic Chemistry from the University of Pennsylvania and an MBA from Penn State University.

About the Science Center
Located in the heart of uCity Square, the Science Center is a mission-driven nonprofit organization that catalyzes and connects innovation to entrepreneurship and technology commercialization. For 50+ years, the Science Center has supported startups, research, and economic development in the life sciences, healthcare, physical sciences, and emerging technology sectors. As a result, graduate firms and current residents of the Science Center’s incubator support one out of every 100 jobs in the Greater Philadelphia region and drive $13 billion in economic activity in the region annually. By providing resources and programming for any stage of a business’s lifecycle, the Science Center helps scientists, entrepreneurs and innovators take their concepts from idea to IPO – and beyond.

For more information about the Science Center, go to http://www.sciencecenter.org

Read the full story at http://www.prweb.com/releases/2017/08/prweb14561634.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Biova Joins the Council for Responsible Nutrition
2. James B. (Jamie) Rogers Joins VIC Technology Venture Development™ Board of Directors
3. Former Associate Director of Product Development R&D at Allergan, Melissa Kirkegaard, joins NDA Partners as Expert Consultant
4. EDETEK Expands Leadership Team - Tom Guinter joins as Vice President, Product Services; Mark Gee joins as Senior Director, Product Business Development
5. Andrew Ondish Joins Sales Team at Graphite Metallizing
6. Paul Barrow Joins Commonwealth Informatics Team
7. Former Vice President of Development Operations at XenoPort, Sami Karaborni, PhD, joins NDA Partners as Expert Consultant
8. PathSensor’s CEO Joins Other Maryland Bio Tech Leaders in Issuing Recommendations to Accelerate Industry Growth
9. Former CEO of Eurofins Advantar Laboratories, Richard Kenley, PhD, joins NDA Partners as Expert Consultant
10. Quorum Review IRB Joins the SMART IRB Platform
11. Rachel Cervantes Joins University City Science Center as VP Corporate Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... 29, 2020 , ... DuPont Nutrition & Biosciences announced today ... new plant operation will provide the local animal production industry with customized solutions ... will improve the flexibility of our offerings to the Chinese animal nutrition market,” ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society announced today ... Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on funding ... of academic research centers in the United States and Europe with expertise in ...
(Date:8/7/2020)... , ... August 06, 2020 , ... ... vaccine industries, announces it has closed on the purchase of greenfield for a ... Conroe, TX and includes over 21 acres in the initial acquisition, with an ...
(Date:7/31/2020)... , ... July 29, 2020 , ... R3 Stem Cell ... for only $3950. With 50 million stem cells total, patients may choose which extremities ... therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord ...
Breaking Biology Technology:
(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical stage ... a COVID cure or vaccine, the global economic downturn will only increase price pressures ... going away and capturing full value from every product launch is critical. However, history ...
(Date:7/10/2020)... ... 09, 2020 , ... Today CJ BIO announced the first in a series ... “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across ... Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the ...
(Date:7/2/2020)... REDWOOD CITY, Calif. (PRWEB) , ... July 01, ... ... stage biotech company, presented its phase 1a findings of Neihulizumab, a biologic for ... annual conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of ...
Breaking Biology News(10 mins):